<ѻý>$150K Prostate Cancer Drug Draws New Attention to 'March-In' Rightsѻý> Advocates want Biden administration to enable Xtandi generics; industry warns against it Apr 06, 2022
<ѻý>New Clue to Risk of Peritoneal Cancer After Prophylactic Salpingo-Oophorectomyѻý> Women with BRCA variant and serous tubal intraepithelial carcinoma had a 34-fold greater risk Apr 05, 2022
<ѻý>Black Patients More Often Get 'Substandard' Care for GI Cancersѻý> Retrospective study finds worse surgical outcomes, lower odds of receiving chemotherapy Apr 04, 2022
<ѻý>Living Donor Transplant Promising for CRC With Liver-Only Metastasesѻý> In small study, researchers see "encouraging" survival outcomes Mar 30, 2022
<ѻý>Pumping (IV) Iron Linked to Varying Anaphylaxis Risk for Older Adultsѻý> Study finds risk was low, but unequal across different products Mar 28, 2022
<ѻý>3D Mammograms Deliver Fewer False-Positive Findingsѻý> However, half of women will have a false positive with annual screening with DBT Mar 25, 2022
<ѻý>Triplet Induction Regimen Bests Doublet for Nasopharyngeal Carcinomaѻý> Three drugs reduced risk of disease failure, but longer follow-up needed to assess OS Mar 25, 2022
<ѻý>Artificial Sweeteners Not So Sweet When It Comes to Cancer Riskѻý> Consumption of certain sugar alternatives linked to a 13% higher risk of developing cancer Mar 24, 2022
<ѻý>Intraperitoneal Carboplatin Boosts PFS in Ovarian Cancerѻý> Should the gynecologic oncology community reconsider IP therapy? Mar 22, 2022
<ѻý>It's Official: Minimally Invasive Hysterectomy Not Safer in Cervical Cancerѻý> Final analysis of LACC trial confirms earlier findings Mar 21, 2022
<ѻý>Novel Fixed-Dose Immunotherapy Combo Wins FDA Approvalѻý> Nivolumab plus relatlimab doubled progression-free survival in unresectable melanoma Mar 21, 2022
<ѻý>Lenvatinib Packaging for Endometrial Cancer Tied to $168 Million in Overspendingѻý> Presenter breaks news at SGO that drug developer commits to overhauling dose reduction program Mar 20, 2022
<ѻý>Selinexor Proves Mettle in Advanced or Recurrent Endometrial Cancerѻý> Benefit was greatest among patients with wild-type p53 cancer in SIENDO trial Mar 20, 2022
<ѻý>Novel ADC Promising in Tough-to-Treat Ovarian Cancerѻý> Ocular AEs an issue with mirvetuximab in folate receptor alpha-high platinum-resistant disease Mar 20, 2022
<ѻý>Add-on Pembrolizumab Tied to Good QoL in Women With Advanced Cervical Cancerѻý> PRO-based analysis of KEYNOTE-826 trial shows favorable benefit-risk ratio Mar 19, 2022
<ѻý>Adjuvant Chemo Disappoints in Low-Grade Serous Ovarian Cancerѻý> Study suggests no improvement in overall survival Mar 19, 2022
<ѻý>Mixed Message for Ultrasound in High-Risk Cutaneous Head and Neck Cancerѻý> Nodal metastasis detected more often than by clinical exam, worrisome false-positive rate Mar 18, 2022
<ѻý>FDA OKs PARP Inhibitor as Adjuvant Therapy in Early Breast Cancerѻý> Olaparib (Lynparza) approved for high-risk patients with germline BRCA mutations Mar 14, 2022
<ѻý>Fluorescence-Guided Lumpectomy Shows Promiseѻý> Imaging system reduced the need for re-excision in one-fifth of patients Mar 11, 2022
<ѻý>More Research Needed on Use of Premium Cigars, Report Findsѻý> These cigars seem less dangerous than cigarettes -- but it's only because of how they are smoked Mar 10, 2022
<ѻý>Fecal Microbiome Markers Detect Pancreatic Cancer With 'High Accuracy'ѻý> These markers need to be tested in a prospective cohort before clinical impact can be determined Mar 10, 2022
<ѻý>Robotic Hepatectomy Shows Benefits Over Laparoscopic Surgeryѻý> Shorter hospital stay, similar perioperative outcomes in matched analysis Mar 10, 2022
<ѻý>Radioiodine for Low-Risk Thyroid Cancer: Yea or Nay?ѻý> Randomized study finds no meaningful difference in events of abnormalities between groups Mar 09, 2022
<ѻý>Another Casualty of COVID-19: Evidence-Based Medicineѻý> Physician laments decline in research quality, critical appraisal during pandemic Mar 09, 2022
<ѻý>Androgen Receptor Agonist Active in Resistant ER+ Breast Cancerѻý> Also: Combination targets uncommon form of advanced HER2-mutant disease Mar 09, 2022
<ѻý>Is ctDNA Useful for Surveillance in Resected CRC?ѻý> Small study suggests no advantage compared to imaging alone or with CEA measurement Mar 08, 2022
<ѻý>More Options for Precision Medicine in Metastatic Triple-Negative Breast Cancerѻý> Moving beyond chemotherapy to immunotherapy, PARP inhibitors, ADCs, combinations Mar 08, 2022
<ѻý>9/11 Responders More Likely to Carry Genetic Mutations Tied to Cancerѻý> Clonal hematopoiesis seen in 10% of firefighters, medical personnel on the scene after WTC attack Mar 07, 2022
<ѻý>Chipping Away at the Dogma of Axillary Dissection in Breast Cancerѻý> Ongoing trials could help some women avoid even less-invasive sentinel lymph node biopsy Mar 07, 2022
<ѻý>Clinical Picture Brightens for HER2+ Breast Cancer With Brain Metastasesѻý> New therapies breach blood-brain barrier to improve response, survival Mar 07, 2022
<ѻý>Honing the Indications for Adjuvant CDK4/6 Inhibition in Breast Cancerѻý> Defining high risk, considering role of Ki-67, BRCA mutations Mar 05, 2022
<ѻý>Check Troponin in RCC Patients Before Checkpoint-VEGFR Inhibitor Comboѻý> In JAVELIN Renal 101, those with high levels had more heart events with avelumab-axitinib Mar 05, 2022
<ѻý>Cancer May Heighten Odds of Guillain-Barre Syndromeѻý> Link strongest with hematologic malignancies as well as prostate, breast, and respiratory cancers Mar 03, 2022
<ѻý>ARB-Cancer Link May Come Down to Cumulative Exposureѻý> Does a new paper resolve the conflicting safety data on the popular antihypertensives? Mar 02, 2022
<ѻý>Kids With IBD Need Close Monitoring as They Grow Upѻý> Meta-analysis confirms: substantially increased cancer risk in adulthood Mar 02, 2022
<ѻý>Novel Therapies Active in Head and Neck Cancersѻý> High response rate with oncolytic virus plus immunotherapy in cutaneous lesions Feb 28, 2022
<ѻý>AI Platform Near Perfect for Predicting Thyroid Malignancyѻý> High precision for T stage, extracapsular extension, BRAF mutation Feb 27, 2022
<ѻý>Merkel Cell Carcinoma Much More Likely to Recur vs Other Skin Cancersѻý> 5-year recurrence rate was 40% compared with 19% for melanoma Feb 23, 2022
<ѻý>PD-L1 Inhibitor Fails to Meet PFS Target in Advanced Penile Cancerѻý> Atezolizumab did show some activity, with a 30% overall response rate Feb 22, 2022
<ѻý>Enfortumab Vedotin Promising in Neovadjuvant Therapy in Advanced Bladder Cancerѻý> Early-phase study offers 36% pCR in cisplatin-ineligible patients with muscle-invasive disease Feb 19, 2022